190 related articles for article (PubMed ID: 11234879)
21. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
23. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
24. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
25. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
[TBL] [Abstract][Full Text] [Related]
26. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
[TBL] [Abstract][Full Text] [Related]
27. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
[TBL] [Abstract][Full Text] [Related]
30. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
31. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.
Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A
Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
34. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Smad nucleocytoplasmic shuttling in living cells.
Nicolás FJ; De Bosscher K; Schmierer B; Hill CS
J Cell Sci; 2004 Aug; 117(Pt 18):4113-25. PubMed ID: 15280432
[TBL] [Abstract][Full Text] [Related]
37. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.
Sakellariou S; Liakakos T; Ghiconti I; Hadjikokolis S; Nakopoulou L; Pavlakis K
Anticancer Res; 2008; 28(2A):1079-83. PubMed ID: 18507057
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of CD83 positive tumor-infiltrating dendritic cells and expression of TGF-beta 1 in human gastric cancer.
Ananiev J; Gulubova MV; Manolova IM
Hepatogastroenterology; 2011; 58(110-111):1834-40. PubMed ID: 22086706
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta signalling from cell membrane to nucleus through SMAD proteins.
Heldin CH; Miyazono K; ten Dijke P
Nature; 1997 Dec; 390(6659):465-71. PubMed ID: 9393997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]